Search

Displaying results 6811 - 6820 of 6949 in total
  1. Drug

    Rusalatide

    go.drugbank.com/drugs/DB05309
    Investigational

    TP508 is a non-proteolytic synthetic peptide representing the portion of human thrombin originally identified as the fibroblast high-affinity receptor binding domain.

  2. Drug

    ACR-16

    go.drugbank.com/drugs/DB05371
    Investigational

    ACR-16 is under investigation by NeuroSearch. ACR16 has been successfully investigated in a Phase II multi-centre, randomised and placebo-controlled trial in patients with Huntington’s disease as well as in three Phase Ib studies within ...

  3. Drug

    CP-122721

    go.drugbank.com/drugs/DB05421
    Experimental

    CP-122721, neurokinin 1 (NK1) antagonist is developed by Pfizer to treat depression, emesis, and inflammatory diseases including asthma and irritable bowel syndrome.

  4. Drug

    MLN-977

    go.drugbank.com/drugs/DB05431
    Experimental

    MLN-977 is a small molecule compound that inhibits the production of leukotrienes, especially 5-lipoxygenase. It is developed by PharmaEngine to treat asthma and chronic obstructive pulmonary disease.

  5. Drug

    INO-1001

    go.drugbank.com/drugs/DB05549
    Investigational

  6. Drug

    Apilimod

    go.drugbank.com/drugs/DB05611
    Investigational

  7. Drug

    OPC-51803

    go.drugbank.com/drugs/DB05838
    Experimental

    OPC-51803 is the first nonpeptide vasopressin (AVP) V(2)-receptor-selective agonist.

  8. Drug

    NCX 950

    go.drugbank.com/drugs/DB05849
    Experimental

    NCX 950, beta2-adrenoceptor agonists is widely used in the treatment of pulmonary diseases.

  9. Drug

    Pegnivacogin

    go.drugbank.com/drugs/DB06293
    Investigational

  10. Drug

    Mirostipen

    go.drugbank.com/drugs/DB06453
    Experimental